AIDS Therapy

China approves generic anti-AIDS drug

Published in AIDS Weekly, October 14th, 2002

A Chinese pharmaceutical company said September 16, 2002, that it has received permission from regulators in Beijing to make a generic copy of a powerful anti-AIDS drug patented in China by a U.S. company.

Desano Shanghai will be allowed to make a low-cost version of dd1, a widely used drug that slows the effects of AIDS, said Li Jinliang, the company's deputy manager.

Bristol-Myers Squibb holds a patent in China for dd1. A spokesman for the New York-based pharmaceutical company said it only covers the drug in tablet form. He said Desano Shanghai's generic version is exempt because it is a powder.

"They are free to make this,"...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2002-10-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry